1 documents found
Information × Registration Number 0218U000578, 0116U000178 , R & D reports Title To substantiate the application and study the effectiveness of new complex colloid infusion drugs (laboratory experimental and clinical study) popup.stage_title Head Kondratskyi Bogdan O., Novak Vasyl' L., Registration Date 02-02-2018 Organization LVIV RESEARCH INSTITUTE OF BLOOD PATHOLOGY AND TRANSFUSIONAL MEDICINE popup.description2 Experimentally proved that the introduction of colloidal hyperosmolar solution HAES-LX-5% has the ability to prevent clot formation processes in rats with acute ischemic stroke. The results of the study of the effect of HAES-LX-5% on the development of changes in the renal tissue on the model of burn disease in rats are presented. The data of morphological changes in organs of experimental animals after introduction of super-high doses of the new protein-salt preparation ALX-5% and concentrated 2 times solution of ALX-2N are presented. The results of a clinical study of the previously developed preparation Rheosorbilact in cancer patients with antral gastric cancer after subtotal resection of the stomach (35 patients) are presented. Product Description popup.authors Івасик Віктор Володимирович Брагінець Олена Григорівна Винарчик Марія Йосипівна Городиська Олена Олександрівна Деркач Юлія Володимирівна Дзісь Богдан Романович Дзісь Роман Петрович Качмарик Діана Любомирівна Кондрацький Ярослав Богданович Панас Оксана Михайлівна Примак Софія Василівна Семененко Андрій Ігорович Семененко Оксана Миколаївна popup.nrat_date 2020-04-02 Close
R & D report
Head: Kondratskyi Bogdan O., Novak Vasyl' L.. To substantiate the application and study the effectiveness of new complex colloid infusion drugs (laboratory experimental and clinical study). (popup.stage: ). LVIV RESEARCH INSTITUTE OF BLOOD PATHOLOGY AND TRANSFUSIONAL MEDICINE. № 0218U000578
1 documents found

Updated: 2026-03-27